Skip to main content
Otsuka Holdings Co., Ltd. logo

Otsuka Holdings Co., Ltd. — Investor Relations & Filings

Ticker · 4578 ISIN · JP3188220002 T Manufacturing
Open in API
Filings indexed 89 across all filing types
Latest filing 2022-03-31 Governance Information
Country JP Japan
Listing T 4578

About Otsuka Holdings Co., Ltd.

https://www.otsuka.co.jp/en/

Otsuka Holdings Co., Ltd. is a global healthcare company dedicated to creating innovative products for better health worldwide. The company operates through two core segments: a Pharmaceutical business and a Nutraceutical business. The Pharmaceutical division focuses on the research, development, and commercialization of treatments for diseases, with key areas including central nervous system disorders, oncology, cardiovascular diseases, and infectious diseases. The Nutraceutical division provides products based on scientific evidence to support daily health maintenance and improvement. This segment includes a wide range of functional foods, nutritional supplements, functional beverages, and cosmeceuticals, with well-known brands such as POCARI SWEAT, Calorie Mate, and Nature Made.

Recent filings

Filing Released Lang Actions
内部統制報告書－第14期(令和3年1月1日－令和3年12月31日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act (金融商品取引法). This type of report is a mandatory regulatory filing in Japan that assesses the effectiveness of a company's internal controls over financial reporting. Since it is a specific regulatory requirement distinct from a full annual report (10-K) or a simple announcement, and it does not fit into the other specific categories like audit reports or governance reports, it is best classified as a Regulatory Filing (RNS).
2022-03-31 Japanese
有価証券報告書－第14期(令和3年1月1日－令和3年12月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuuka Shouken Houkokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains the standard cover page, fiscal year information (2021-01-01 to 2021-12-31), and extensive XBRL tagging data related to financial statements and corporate governance. It is a comprehensive annual filing, not an announcement or a summary. FY 2021
2022-03-31 Japanese
四半期報告書－第14期第3四半期(令和3年7月1日－令和3年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (第３四半期報告書) for Otsuka Holdings Co., Ltd. It contains detailed financial statements, management analysis (MDA), and segment performance for the third quarter of 2021. It is a formal regulatory filing submitted to the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It is not an announcement or a summary, but the full report itself. 9M 2021
2021-11-12 Japanese
四半期報告書－第14期第2四半期(令和3年4月1日－令和3年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Otsuka Holdings Co., Ltd. for the second quarter of the fiscal year 2021. It contains detailed financial statements, management analysis (MDA), and business performance metrics, which are characteristic of an interim/quarterly report. It is not an announcement of a report, but the report itself, and it contains substantive financial data. H1 2021
2021-08-06 Japanese
四半期報告書－第14期第1四半期(令和3年1月1日－令和3年3月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Otsuka Holdings Co., Ltd. for the first quarter of the 14th fiscal year (January 1, 2021, to March 31, 2021). It contains detailed financial statements, management analysis (MDA), and business performance metrics. According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year that contains actual financial statements is classified as an Interim / Quarterly Report (IR). Q1 2021
2021-05-14 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act, signed by the CEO and CFO of Otsuka Holdings. It serves as an officer certification attesting to the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report, should be classified as Regulatory Filings (RNS) rather than the report itself. FY 2020
2021-03-31 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.